Evidence map›Paper›PMID 23578364›Full record

ArticleJournal of agricultural and food chemistry2013

Dietary flavonol epicatechin prevents the onset of type 1 diabetes in nonobese diabetic mice.

Zhuo Fu, Julia Yuskavage, Dongmin Liu

Abstract read
In one paragraph

Article in Journal of agricultural and food chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Current drug discovery technologies · 2024
    Review
  3. Journal of traditional and complementary medicine · 2023
    Article
  4. Green tea and metabolic syndrome: A 10-year research update review.Iranian journal of basic medical sciences · 2021
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Phytochemical profile ofPhytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zhuo FuDepartment of Human Nutrition, Foods and Exercise, College of Agriculture and Life Sciences, Virginia Tech, Blacksburg, Virginia 24061, United States.
Julia Yuskavage
Dongmin Liu
Virginia Tech · US

Funding

Identification and molecular characterization of anti-diabetic flavonoidsR01AT007077 · NCCIH · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI LIU, DONGMIN · 2012 to 2016
$1.9M
Genistein for the Prevention and Treatment of Diabetic Vascular InflammationR21AT004694 · NCCIH · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI LIU, DONGMIN · 2008 to 2009
$649k
NCCIH NIH HHS 1R01AT007077-01NCCIH NIH HHS 1R21AT004694NCCIH NIH HHS R01 AT007077NCCIH NIH HHS R21 AT004694
6 · The paper itself

Abstract

Type 1 diabetes (T1D) is an autoimmune disease characterized by the selective destruction of pancreatic β-cells. Although successful islet transplantation provides a promising treatment, high cost, lack of donor organs, immune-mediated destruction of transplanted islets, and side effects from immunosuppressive drugs greatly limit its uses. Therefore, the search for novel and cost-effective agents that can prevent or ameliorate T1D is extremely important to decrease the burden of T1D. In this study, we discovered that epicatechin (EC, 0.5% in drinking water), a flavonol primarily in cocoa, effectively prevented T1D in nonobese diabetic (NOD) mice. At 32 weeks of age, 66.7% of control mice had overt diabetes, whereas only 16.6% of EC-treated mice became diabetic. Consistently, EC mice had significantly higher plasma insulin levels but lower glycosylated hemoglobin concentrations compared to control mice. EC had no significant effects on food or water intake and body weight gain in NOD mice, suggesting that EC's effect was not due to alterations in these variables. Treatment with EC elevates circulating anti-inflammatory cytokine interleukin-10 levels, ameliorates pancreatic insulitis, and improves pancreatic islet mass. These findings demonstrate that EC may be a novel, plant-derived compound capable of preventing T1D by modulating immune function and thereby preserving islet mass.

Indexed as

Dietary SupplementsAnimalsAutoimmune DiseasesCatechinCytokinesDiabetes Mellitus, Type 1FastingFemaleGlucose Tolerance TestGlycated HemoglobinInsulinInsulin-Secreting CellsInterleukin-10Interleukin-12Islets of LangerhansMiceCatechinCytokinesGlycated HemoglobinInsulinInterleukin-10Interleukin-12

Identifiers

PMID23578364
PMCPMC3660227
OpenAlexW1980456810

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.